UK warns drug firms to stockpile in case of Brexit disruption

UK warns drug firms to stockpile in case of Brexit disruption Companies should ensure six weeks’ worth of drugs for end of transition period, DHSC says

Pharmaceutical companies should stockpile six weeks’ worth of drugs to guard against disruption at the end of the Brexit transition period, the government has said.

The Department of Health and Social Care (DHSC) has written to medicine suppliers advising them to make boosting their reserves a priority. The Guardian

See also:

• Detailed guide: Government contacts to help medical supply businesses after 31 December 2020 Department of Health and Social Care
• Correspondence: Letter to medicines and medical products suppliers: 3 August 2020 Department of Health and Social Care